QA: Clovis Oncology Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001466301_2022_Clovis_Oncology_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001466301, Clovis Oncology Inc

  xvar xval
0 AssetsCurrent 198,087,000
1 IntangibleAssetsNetIncludingGoodwill 123,445,000
2 PropertyPlantAndEquipmentNet 6,554,000
3 remainder_Assets 144,747,000
4 LiabilitiesCurrent 125,214,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 626,459,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 110,566,757
9 ResearchAndDevelopmentExpense 204,367,636
10 remainder_Expenses 54,615,593
11 remainder_Revenues 122,955,287
12 remainder_NetIncome -48,204,181
13 remainder_ComprehensiveNetIncome 849,007
  yvar yval
0 Assets 472,833,000
1 Liabilities 751,673,000
2 Expenses 369,549,986
3 Revenues 122,955,287
4 StockholdersEquity -278,840,000
5 NetIncome -294,798,880
6 ComprehensiveNetIncome -294,374,376
7 BaseVar 883,032,230
8 EconomicCapitalRatiobeforeLimitedLiability -1.47
9 EconomicCapitalRatio 1.19

Edgar->Model Mapping

Feature Distribution

Change over Time